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Abstract: The use of Carbon Nanotubes (CNT) and Graphene increased in the last decade and it is
likely to keep increasing in the near future. The attractiveness of their properties, particularly the
possibility to enhance the composites performance using a tailor made methodology, brings new
materials, processes and products for highly demanding industrial applications and to the market.
However, there are quite a lot of health/safety issues, as well as lack of understanding and standards
to evaluate their effects. This paper starts with a general description of materials, processes and
products dealing with CNT and graphene. Then, an overview of concerns related to the health
and safety when handling, researching, producing and using products that include these materials
is presented. It follows a risk management approach with respect to simulation and evaluation
tools, and considering the consensual limits already existing for research, industry and consumers.
A general discussion integrating the relevant aspects of health and safety with respect to CNT and
graphene is also presented. A proactive view is presented with the intention to contribute with
some guidelines on installation, maintenance, evaluation, personal protection equipment (PPE) and
personnel training to deal with these carbon-based nanomaterials in research, manufacture, and use
with composite materials.
Keywords: CNT; graphene; health; safety; risk management; composite materials
1. Introduction
In this century, the field of nanotechnology has risen to the forefront of research and development,
standing out the carbon nanoallotropes. The specific and excellent properties of CNTs and graphene
pave the way to an ever-increasing number of applications, such as medical devices and drugs,
energy, environment, biology, aerospace, aeronautics, automotive, sports, electronics, solar cells,
structural batteries, adhesives, composites, polymers, super capacitors, ultra-stiff materials, gas sensors,
biosensors, wastewater treatment, reinforced rods, mechanical memories, coatings, and films [1–6].
In fact, they present high tensile strength and modulus, high thermal and electrical conductivities, high
absorbency and aspect ratio and low weight, which means that these nanomaterials have very high
specific properties. However, the health and safety implications of Engineered nanomaterials—ENM,
including CNT and graphene, are far away from being understood and full of uncertainties. In fact,
the high exposures are likely to cause harm to the researchers in laboratories, workers in industrial
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production sites or in the waste, recycling industries, consumers, and environment [3–5,7]. Therefore,
it is essential to assess the short, medium and long-term effects and potential risks [8,9].
Both academic laboratories and industries, where the work in the field of nanotechnology is
very active, it is particularly important to prevent and mitigate the risks associated with the handling,
producing and transforming nanomaterials by establishing laboratory procedures and guidelines to
avoid unexpected and unnecessary concerns [9,10]. Decision makers, researchers, production and
maintenance workers must evaluate risks and take the precautionary measures to have a safer working
atmosphere [11]. Nanosafety must be considered in the development phase, covering the total life
cycle, ensuring that nanotechnology may provide answers to society needs [12]. The aim of this paper
is to contribute to these goals.
Starting with a brief description of materials, processes and final products that deal with CNT
and graphene, the paper presents the more relevant health and safety concerns before going to the
risk assessment methodologies. After a general discussion, we move to a proactive view where some
guidelines will be addressed.
To develop the proposed work a holistic review was performed based on diverse bibliography
concerning the health and safety issues related to CNT and graphene products, mainly on the reported
literature from 2000 to 2020. The literature review was carried out using search engines, and other
databases, with the following search strategy: combination of the keywords and sub-keywords;
selection of the relevant articles by reading the title and abstract; and, full text reading of the selected
articles. After selecting the items, a critical analysis was performed.
2. State of the Art Review
The main aim of this systematic review was to evaluate briefly the state of art of the health
and safety concerns related to CNT and graphene products, including composite systems with
these nanomaterials.
Therefore, firstly in this section, the use of nanomaterials will be described, how they are produced
and processed to yield a product with enhanced properties, following a systematic review related to
the ENM and their applications.
Secondly, an overview of concerns related to the health and safety when handling, researching,
producing and using products that include these nanoengineered materials is presented, bearing in
mind exposure in occupational operations and end users practices.
At last, the risk management approaches are presented in terms of simulation and evaluation
tools for research, industry and consumers’ management.
2.1. Materials
Different types of carbon engineered nanomaterials derived from graphene (Figure 1) can be
considered: fullerenes, carbon nanotubes, graphene and their derivatives [13]. They have attracted
worldwide applications (energy, aeronautics, environment, biology, medicine, etc.), due to their unique
properties that make them promising candidates for a wide range of applications.
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Figure 1. Relation between graphene and other carbon allotropes, adapted from [13]. 
Carbon-based nanomaterials can appear with different aspects and morphologies, such as 
hollow tubes, ellipsoids, platelets or spheres [1]. Fullerenes, such as C60, carbon nanotubes (CNTs), 
carbon nanofibers (CNFs), carbon black and graphene are all included under the carbon-based 
nanomaterials category [14]. These are considered of particular interest as nanoreinforcements to the 
Carbon Fibre Reinforced Polymer (CFRP) composites community, showing the ability to improve 
their global performance, as can be seen in Table 1 [2]. 
Table 1. Some changes induced by the carbon nano allotropes addition to CFRP. 
Type ϕ a (nm) Content (wt. %) Relevant Property Improvements 
Carbon 
Nanofibres 
60 to 200 2.0 +22% Flexural strength 
+11% Tensile strength 
+4% Glass transition temperature [15] 
~200 0.3 +79% Impact absorption energy 
+42% Inter-laminar shear strength 
+14% Flexural strength [16] 
Multiwalled 
carbon nanotubes 
10 to 20 0.3 +25 % Flexural strength [17] 
~10 0.5 +3% Tensile strength [18] 
30 to 50 0.3 +53% Flexural modulus [19] 
Graphene 8 0.1 +11% Fracture toughness [20] 
5 0.4 +19% Tensile modulus 
+18% Tensile strength 
+19% Flexural modulus 
+15% Flexural strength [21] 
100 4 +19% Interlaminar Shear Strength 
+26% Flexural modulus (90°) 
+82% Flexural strength (90°) 
+4% Flexural modulus (0°) 
+7% Flexural strength (0°) 
+167% Electrical conductivity [22] 
a Average diameter or length/thickness. 
The Single Wall Carbon Nanotubes (SWCNTs) and Multi-Walled Carbon Nanotubes 
(MWCNTs) may have similar lengths, ranging from hundreds of nanometers to tenths of 
micrometers, although they have also different diameter ranges. The SWCNTS have typical 
l ti t
Figure 1 shows graphene as the building block of all graphitic arbon allotropes with different
dimensionaliti s [13].
Carbon-based nanomaterials can appe r with diff rent aspects and morphologies, such as hollow
tubes, ellipsoids, platelets or spheres [1]. Fullerenes, such as C60, carbon tubes (CNTs), carbon
n nofibers (CNFs), carbon black and graphene are all included under t e carbon-based nan materials
category [14]. These are considered of particular interest as nanoreinforcements to the Carbon Fibre
Reinforced Polymer (CFRP) composites community, showing the ability to improve their global
performance, as can be se n in Table 1 [2].
Table 1. Some changes induced by the carbon nano allotropes addition to CFRP.
Type φ a (nm) Content (wt. %) Relevant Property Improvements
Carbon
Nanofibres
60 to 200 2.0 +22% Flexural strength
+11% Tensile strength
+4% Glass transition temperature [15]
~200 0.3 +79% Impact absorption energy
+42% Inter-laminar shear strength
+14% Flexural strength [16]
Multiwalled
car a otubes
10 to 20 0.3 +25 % Flexural strength [17]
~10 0.5 +3% Tensile strength [18]
30 to 50 0.3 +53% Flexural modulus [19]
Graphene
8 0.1 +11% Fracture toughness [20]
5 0.4 +19% Tensile modulus
+18% Tensile strength
+19% Flexural modulus
+15% Flexural strength [21]
100 4 +19% Interlaminar Shear Strength
+26% Flexural modulus (90◦)
+82% Flexural strength (90◦)
+4% Flexural modulus (0◦)
+7% Flexural strength (0◦)
+167% Electrical conductivity [22]
a Average diameter or length/thickness.
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The Single Wall Carbon Nanotubes (SWCNTs) and Multi-Walled Carbon Nanotubes (MWCNTs)
may have similar lengths, ranging from hundreds of nanometers to tenths of micrometers, although
they have also different diameter ranges. The SWCNTS have typical diameters between 1 and 3 nm,
whilst MWCNTs range from 10 to 200 nm. Similarly, graphene flakes present thicknesses of one carbon
atom while their lateral dimensions may vary from hundreds of nanometers to hundreds of microns.
From graphene to a few-layer graphene and graphite, flakes with increasing thickness are also available.
The size and shape aspects of these nanoparticles should be accounted for assessing health and safety
issues [1,3,11,14,23].
The CNTs and CNFs are available as liquid dispersions, dry powders or embedded in polymers
as nanocomposites or CFRP composites [23]. For many applications, it is necessary to modify and
functionalize the CNTs surface, aiming at ensuring a better compatibility and a stronger interface
between the nanofiller and the polymeric matrix.
2.2. Processes
The combination between the remarkable structural performance of continuous carbon fibres
(CFs) with the multifunctional properties of carbon-based nanomaterials allows the development of
novel nanoengineered (multiscale) CFRP composites (Figure 2) with interesting synergies [1].
J. Compos. Sci. 2020, 4, x 4 of 25 
 
diameters between 1 and 3 nm, whilst MWCNTs range from 10 to 200 nm. Similarly, graphene flakes 
present thicknesses of one carbon atom while their lateral dimensions may vary from hundreds of 
nanometers to hundreds of microns. From graphene to a few-layer graphene and graphite, flakes 
with increasing thickness are also available. The size and shape aspects of these nanoparticles should 
be accounted for assessing health and safety issues [1,3,11,14,23]  
The CNTs and NFs are available as liquid dispersions, dry powders or emb dded in polymers 
as nanocomposites or CFRP composites [23]. For many appli ations, it is necessary to modify and 
functionalize the CNTs surface, aiming at ensuring a better compatibility and a stronger interface 
between the nanofiller and the polymeric matrix. 
2.2. Processes 
The combination between the remarkable structural performance of continuous carbon fibres 
(CFs) with the multifunctional properties of carbon-based nanomaterials allows the development of 
novel nanoengineered (multiscale) CFRP composites (Figure 2) with interesting synergies [1].  
 
Figure 2. Typical scenario of the production of a multifunctional CFRP by incorporating nanofillers 
[1]. 
The combination of carbon-based nanoreinforcements with conventional fibre reinforcements in 
polymer composites may be achieved through different routes, namely, dispersing in the polymer 
matrix, growing on fibres, interleaving buckypapers and stitching the nanomaterials onto the fibres 
[24]. 
There have been various approaches to improve the dispersion and the interaction between the 
carbons-based reinforcements and the thermoset polymers, which can be divided into two main 
categories of chemical and mechanical approach. The chemical approach focuses on the creation of 
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In order for the nano modified thermosetting polymers to penetrate into the primary fibre tows, 
filtration effects need to be minimized, usually by using low loading fractions and small/short 
nanomaterials to produce the hybrids composites. Manufacturing processes for advanced composites 
include methods such as hand lay-up, resin transfer moulding (RTM), compression moulding, 
filament winding, autoclave curing, vacuum-assisted resin transfer moulding (VARTM), among 
others. Some of these advanced fabrication techniques enable structural composites to be 
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other properties. Nevertheless, manufacture of high performance composites using nano modified 
prepregs with autoclave curing has been “the gold standard” established by aerospace industry 
[31,32] 
Figure 2. Typical scenario of the production of a multifunctional CFRP by incorporating nanofillers [1].
The combination of carbon-based nanoreinforcements with conventional fibre reinforcements
in polymer composites may be achieved through different routes, namely, dispersing in the polymer
matrix, growing on fibres, interleaving buckypapers and stitching the nanomaterials onto the fibres [24].
There have been various approaches to improve the dispersion and the interaction between
the carbons-based reinforcements and the ther oset polymers, which can be divided into two main
categories of ch mical and mech ical app oach. The chemical approach focuses n the creation
of chemical bonding between the anotubes and the polymer m trix. The chemical approach
includes: (1) the creation of non-covalent bon ing by the solvent and surfactant-assisted dispersion,
and (2) the creation of covalent bonding by the surface functionalization of the nanomaterials.
While the mechanical approach mainly employs the sophisticated mixing methods (Figure 3), such as:
(1) dispersing the particles into the matrix with the help of sonication and or (2) by high shear mixing
(three-roll milling) [25–30].
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Melt-mixing routes are commonly used to prepare CNT-polymer and graphene-polymer
nanocomposites within the thermoplastics industry, making them available at large scale. Typically,
the polymer nanocomposites are produced by twin-screw extrusion and are available in the form
of pellets, ready for the application in industrial processes, as injection moulding, extrusion blow
molding, filament drawing, among others [33].
2.3. Products
The typical properties of conve tional CFRPs, i cluding high stiffness, strength-to-weight ratio,
fatigue t lerance and electrical conductivity re strongly depe dent on the CFs orientation. After the
great success of manufacturing high performance CFRP, scientists have continued exploring the world
of carbon-bas d materials, since the out-of-plane properties of composites are mainly dominated
by the insulating and brittle nature of the thermoset or more ductile thermoplastic polym rs [1].
Henc , the modification of these polymeric matrices with c rbon llotropes has proved to ov rcome
some of those limitations [34]. Through the incorporation of nanomaterials, at ultralow percolation
t res olds, advanced, lightweight and smart CFRPs with integrated novel functionalities have been
successfully developed [35]. These nanostructures ave brought various extraordinary properties
such s electrical, mechanical, thermal and “smart” properties [36–39]. For example, t formation
of a conductive network establish d between the well dispersed carbon-based nanomaterials within
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polymeric matrices allows the communication and interaction with the surrounding environment,
and the response accordingly to the external stimuli (self-sensing) [26].
At present, information of CNT and graphene products that are already on the market are listed in
the inventory compiled by StatNano [40]. In this database a total of 172 products are listed containing
these nano carbon allotropes (Figure 4), for a diverse range of applications, among which health and
fitness products constitute the largest category. In addition, it is reported that companies based in
the United States share more than 43% of the total products, followed up by UK with 40%. It is also
possible to observe a large number of research papers and patents from the aerospace, aeronautics,
automotive, defence, medical and construction industries related with CNTs and graphene, the main
investigation focus being the enhancement of specific properties and/or providing functionalities to a
given product [40].J. Compos. Sci. 2020, 4, x 6 of 25 
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2.4. Health
From early nanotoxicological studies, it became apparent that, due to their unique
physicochemical properties, nanomaterials behaved differently from common chemicals. In fact,
most of the nanoparticles are insoluble by nature and, at the same ti e, they can be dispersed and
remain stable within a solution [41]. So, the health and safety concerns about the different types of
carbon nanoparticles have been addressed for almost two decades, however consensus on this topic
is still far from being reached [5,42].
These nanoscale materials present low bulk density, constituting a safety hazard even when used
in small quantities for research purposes (in the order of µg, mg or g). Due to their nanoscale size,
these particles may remain suspended in the air for considerable time. For example, their open-air handling
can promote the material loss to the atmosphere (environment) and result in potentially harmful exposure,
either by dermal contact or inhalation, to researchers and workers [10,43,44]. In fact, the uptake of
nanoparticles by inhalation has been described as one of the main routes for contamination of lab workers,
which in the long-term may result in breathing problems or even create more serious diseases [43–45].
In general, humans are likely to be exposed to effects of nanoparticles from nanoengineered
aterials also by ingestion, apart from inhalation and skin uptake [46]. Depending upon the
manufacturing and processing techniques, CNTs and graphene are likely to be a concern for human
health, as they can be released to the environment by several mechanisms, including wear and abrasion
of the final product. They may cause dermal effects, inflammation, mutagenesis, interstitial fibrosis,
lung tumours and vascular effects (Figure 5) [23,47–49]. In addition, these nanoparticles may access
the central nervous system by the following routes [49,50]:
1. Systemic—affecting semi permeable barriers (blood-brain and blood-spinal cord) of the central
nervous system.
2. Olfactory neurodegenerative diseases—due to the direct brain delivery of particles.
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3. Trigeminal—the route uses the trigeminal nerve as an important way to transport from nose to
brain, i.e., intracellular or axonal transport.
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The CNTs induce toxicity, such as oxidative damage in biological systems and influence the
central nervous system, trough endothelial cell damage [46]. Additionally, due to the batch-to-batch
variations nanoengineered materials parameters may change with time, implying possible changes in
the toxicological effects (Figure 6). This means that CNTs and graphene need to be fully characterized,
in short and long term, and have a specific toxicity (eco) assessment, as well as rendering hazard and
risk evaluation [41,47,51].
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Vascular effects induced by CNTs have been reported through different mechanisms. It may
cause progression of atherosclerotic plaque, changes in blood pressure and heart rates, as well as
vasomotor dysfunctions [52]. However, these drawbacks are more common with pristine CNTs,
since functionalization may lead to less damage effects.
2.5. Safety
The production of CNT, graphene and other derivatives, their chemical functionalization, as well as
the modification of polymers and CFRPs, by incorporating these nanomaterials, leads to different
levels of the workers’ exposure. From the synthesis to the different applications with the downstream
nanoparticle use for further dispersion and processing into products, or surface treatment, different
forms of exposure (e.g., powder, liquid and “solid” states) are involved [1].
Preventive safety measures must be applied to all workers (i.e., researchers, engineers, technicians,
chemists and even managers) that are involved in the different phases of the production of CFRPs
with carbon nano allotropes, although considering different levels of exposure [23]. A clear definition
for limit levels of exposure is necessary for each role in the process, for each nanomaterial and for
each process route. Moreover, the increasing evidence that people already with respiratory diseases
are likely to be more susceptible to damage effects [53,54], for safety reasons the exposure limits and
the likelihood of a person to work with nanoengineered materials need to be objectively evaluated.
Safety data sheets must be provided for the life cycle of all nanoengineered materials [55]. They must
include product, hazards, company identification, and safety exposure limits. The determination of
Occupational Exposure Limits (OEL) [11] and users’ limits are of paramount importance. Although
admitting incertitude, some recommended exposure levels were presented, namely 1 µg/m3 elemental
carbon in a respiratory mass 8-h time-weighted average (TWA) concentration [56], but the knowledge
in this area still does not ensure nanotechnology safety [57].
Accounting for the considerations above, it can be stated that for safety purposes, scientific and
technical studies must be done to answer the following questions [58]:
• How to overcome limitations of current technologies and techniques?
• What are the most important physical and chemical properties with respect to biological behavior
of ENM, in short, medium and long time?
• What should be the degree of accuracy and how to measure accurately?
• What are the ignition and explosive properties, and their potential risks?
It has been stated [58] that Personal Protection Equipment (PPE), if used properly, may be an
effective way to reduce damage risks when dealing with ENM.
2.6. Risk Management
Naturally, a well-defined risk management evaluation requires the identification and
characterization of the hazards type expected to occur, exposure assessment and potential risks.
Although there are some common features for ENM, in general, a methodology for a given group
of ENM may not be adequate for another one. Hence, it is important to clearly characterize the
nanomaterial and its potential hazards. Volume Specific Surface Area (VSSA) together with the
nanoparticle size have been reported as complementary criterion for their definition [59].
Exposure to nanomaterials, particularly to ENM, can occur under research activities during
production (with release of nanoparticles to air and water), handling, during service applications
subjected to diverse ageing effects and product end of life, with possible re-use, recycling,
waste treatment and final disposal. For those reasons, the integration of Life Cycle Analysis (LCA)
into risk assessment is highly recommended. In this context, the milestones indicated in Table 2 are
expected to be reached by 2025 [12].
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Aiming to ensure the health and safety of workers, employers have the obligation to conduct regular
risk assessments—as specified in the “Framework” Directive 89/391/EEC—in every aspect related to
their work, particularly when dealing with ENM. Moreover, the Directive 98/24/EC on chemical agents
at work imposes stricter rules for work risk management regarding these substances—particularly, the
hierarchy of prevention measures that strengthens elimination or substitution as priority measures.
This can also be applied to nanomaterials, as they fall within the definition of “substances” [60].
There is no specific legislation applicable to nanoparticles (NP) and nanomaterials.
Some International Organization for Standardization (ISO), American Society for Testing and Materials
(ASTM International) and British Standards Institution (BSI Group) standards applied to these materials
are beginning to emerge. In the traditional risk assessment, the exposure doses are compared to the
occupational exposure limit values (OELs). Since there are no specific OELs for NP, these standards
propose, as a pragmatic orientation, the limit values shown in Table 3 [60].
Table 3. OELs for nanomaterials (NM) [60].
Description Benchmark Exposure Levels
Fibrous; a high aspect ratio insoluble NM 0.01 fibres/ml
Any NM which is already classified in its molecular or in its larger
particle form as carcinogenic, mutagenic, reproductive toxin or as
sensitizing (CMRS)
0.1 × OEL
Insoluble or poorly soluble NM not in the fibrous or CMRS category 0.066 × OEL
Soluble NM not in the fibrous or CMRS category 0.5 × OEL
In addition, the World Health Organization has issued guidelines for the protection of workers to
minimize risks when dealing with nanomaterials [61].
2.6.1. Risk Assessment Methods
Risk assessment involves solving equation 1 and can be evaluated by using semi-quantitative
analyses. Recommended values have been issued by several institutions, such as the French
Agency for Food, Environmental and Occupational Health & Safety method (ANSES), from France;
Control Banding Nanotool (CB Nanotool), from the United States of America—National Institute for
Occupational Health and Safety (NIOSH); École Polytechnique Fédérale de Lausanne method (EPFL),
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from Switzerland; Guidance working safely with nanomaterials and nanoproducts (GWSNN), from
The Netherlands; Istituto Superiore per la Prevenzione e la Sicurezza del Lavoro (ISPESL), from Italy;
Precautionary Matrix for Synthetic Nanomaterials (PMSN), from Switzerland; and Stoffenmanager
Nano, from The Netherlands [62].
Risk= Hazard × Exposure (1)
Table 4 shows an overview of hazard factors defined by each method for a given situation [62].
Table 4. Hazard band factors [62].
Hazard Factor ANSES CB
Nanotool
EPFL GWSNN ISPESL PMSN Stoffenmanager
Toxicity (nano and/or
bulk material)
• • • • •
Solubility • • • • •
Fibre form
(particle shape)
• • • •
Reactivity • • •
Size • • •
Fire and explosion •
Other nanomaterial grouping approaches can be obtained in BSI [63], NIOSH [64] and
BAuA—The Federal Institute for Occupational Safety and Health [65].
In Table 5 the factors that could determine the worker’s exposure are presented.
Table 5. Exposure (or likelihood) band [62].
Exposure Factor ANSES CB
Nanotool
EPFL GWSNN ISPESL PMSN Stoffenmanager
Quantity • • • •
Duration/ frequency
(time) factor











REACH [66] and ECHA [67] may be considered as the most updated documents regarding
regulations and guidance for nanomaterials grouping [51]. Risk estimation and characterization
is defined by REACH [66] and comparing exposure and hazard levels provides the estimate of a
Risk Characterization Ratio, defining process categories versus environmental risk categories. It also
presents an overview of selected risk assessment tools [68].
2.6.2. Research
Nanotechnologies present new challenges regarding risk evaluation and management. Hence,
besides technological developments, research has to be performed for risk evaluation based upon
quantitative data on toxicology and ecotoxicology, and, when necessary, adjusting the assessment
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methodology [69]. Answering to future disruptive scientific and technical challenges in nanoscience’s
and nanotechnologies, while keeping in mind health and safety concerns, is essential to ensure the
competitiveness and economic growth.
2.6.3. Industry
Dealing with polymeric nanocomposites processing requires a safety analysis and preventing
risks, which is the base of the Framework Directive 89/391/EEC. Health and safety at the workplace
is the main driver of this Directive, implying that risk assessments regularly made by the employer.
However, there is nothing specific for nanomaterials. Thus, the suitability of the legal framework is
uncertain or even speculative. Being chemistry involved, nanomaterials are likely to be considered
under the chemicals regulations [60].
A proper legal framework is barely needed in order to regulate the use of NM, and ensure
confidence from cradle to grave [70]. Beyond consistency and avoiding market distortions, harmonized
regulations will guarantee risk minimization and ensure workers’ health and environmental safety.
2.6.4. Application
Even embedded in a matrix, nanoparticles release can occur during all stages, i.e., from cradle
to grave. The probability of exposure must be analysed for the entire life cycle of the nanomaterial,
being the risks evaluation made applying a model close to the one use for natural disasters [60].
Up to now, there are few and limited detailed risk or life cycle studies on the specific impacts of
nanomaterials. Moreover, the waste must be removed from the system following specific protocols;
once the cleaning operation is finished, all waste has to be stored in appropriate containers for further
disposal control [69,71,72].
Prevention is the main action to mitigate possible risks related to nanoparticles and this can start
in the design phase, followed by the safety in the manufacturing process and safe procedures for the
use of the products.
Risk assessment and management must be considered in a life cycle approach and include the
effect of specific nanomaterials in several environmental situations such as air (can nanoparticles with
<70 nm pass through HEPA filters), landfill, waste incineration, sewage and sewage treatment plants
and water [58,73,74].
3. Discussion
CNTs and graphene are valuable raw materials with numerous application in several sectors,
yet legitimate concerns about their potential adverse effects on human and environmental health and
safety need to be addressed. CNTs, due to their morphology (fibre type) have higher potential to be
harmful than other carbon particles forms (i.e., spherical and plates). They can have a higher contact
area with the cell membrane in comparison with particles of different shapes. CNTs are considered
hazardous when thinner than 3 µm and longer than ~20 µm, or when no biodegradation in the lungs by
dissolving or breaking is possible. Moreover, below these dimensions, there is also a clear evidence for
pulmonary and intraperitoneal carcinogenicity of bio persistent nanofibres, and certain MWCNTs [1,75].
Pulmonary fibrosis has also been highlighted as an effect of MWCNT exposure [76,77]. For graphene,
however, there are only few studies that have assessed its toxicity, evidencing that some forms of this
nanomaterial can be a health hazard [47,78,79].
The workers’ exposure to health risks might occur during production, downstream use for further
processing or dispersion into products, and application or treatment of CNT/graphene modified
CFRPs. During the CFRPs production carbon-based nanomaterials can pass through different “states”
(powder, in a liquid resin and inserted into the solidified polymeric matrix), leading to different
exposure degrees, as can be seen in Figure 7 [1].
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19. Software related costs.
An effective health and safety program will reduce potential incidents and, consequently, worker’s
compensation insurance costs [74].
Healthy and safety from cradle to grave will ensure safe innovations in nanomaterials and
products. Nanosafety strategies must start by information gathering to achieve risk mitigation,
followed by hazard and exposure assessment, risk characterization and monitoring [68]. There is
no consensus regarding safe occupational exposure limits for specific CNTs. However, 50 mg/m3 is
indicated [3] as limit concentration based on risk estimation of noncancerous adverse lung effects.
A recommended exposure limit—REL for a working life of 45 years is referred to be 1 µg/m3 [56,81].
Moreover, the proposed occupational exposure limit—OEL for CNTs is suggested to be in the range of
1 to 50 µg/m3 as an 8 hours’ time weighted average—TWA µg/m3 [56]. NIOSH also recommends a
REL 1 µg/m3 for 8-h TWA of exposure to CNTs and CNFs of respirable carbon element [56,81].
From the general review, several authors suggested that the application of the precautionary
principle can be used as a guideline in the environmental decision making process [81].
It is accepted, in general, that CNTs have higher potential to be harmful than other carbon
particles shapes (i.e., spherical and plates), due to higher contact area with the cell membrane in
comparison with other particle shapes. They are considered hazardous when below 3 µm diameter
and longer than ~20 µm, or when no biodegradation in the lungs by dissolving or breaking is possible.
Besides that, below these dimensions, there is also clear evidence for pulmonary and intraperitoneal
carcinogenicity of bio persistent nanofibers, and certain MWCNTs. Furthermore, pulmonary fibrosis
has been highlighted as an effect of MWCNT exposure [33,76,82].
The production of goods incorporating carbon nanomaterials involve the workers’ exposure
during the nanomaterials production, downstream use for further processing or dispersion into matrix
materials, and application or treatment to form the final products. Along the different stages of
carbon-based nanomaterials processing and handling, different exposure degrees are attained.
It should be noted that besides human impacts, the carbon-based nanomaterials also exhibit
toxicity to plants, other animals and microbes [83–85].
Eliminating the risk at source by replacing the potentially hazardous substances by safer ones
appears to be an attractive and cost-effective solution; however, it is hard to apply since the CNTs and
graphene-based products have unique properties desired by the industry.
4. Proposals
Exact exposure assessment methods for nanoparticles have not yet been established, and the
occupational exposure limits for carbon-based nanomaterials have not been set, leading to inconclusive
results and sometimes to inadequate protection measures [33,76,82].
A guidance on the protection of the health and safety of workers from the potential risks related
to nanomaterials at work from the European Commission is available for safe practices [86]. Different
universities, as well as research labs, have also provided guides on their websites for working with
nanomaterials, which mainly involve following standard protocols similar to those existent for other
materials with known or uncertain toxicity, whose goal is mainly to prevent any type of exposure [87,88].
In this section, a proactive view is proposed aiming to contribute with general guidelines on
technical, maintenance, evaluation, personal protection (PPE) equipment and personnel training to deal
with CNT and nano graphene products in research, manufacturing and use with composite materials.
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4.1. Technical
Technical measures comprise the infrastructures, construction of buildings, warning systems,
installations and building layout. These measures are designed and implemented in the building,
to ensure the collective protection of the workers, against multiple risks that may affect their health or
safety at work.
The effect of the controls can be expressed as the protection factor (PF). It is defined as the ratio of
exposure level (either mass-based or particle-based) without the controls divided by the exposure level
with the controls (PF > 1 controls reduce exposure; a PF of 10 indicates that controls reduce exposure
by 90%) [61].
4.1.1. Laboratory
By using appropriate equipment and proper lab practices, it is possible to reduce the risks
associated with the manipulation of nanomaterials [43,89].
The recommended technical protective measures in the laboratories are the following [90]:
• Ventilation:
# With renewal without recycling 5–10×/h,
# With at least a sealed F7/H14 filter (EN 779) for exiting air, since these filters have 80–90%
average efficiency for 0.4 µm particles,
# Low pressure room,
# Capture of the contaminate air at the source.
• A seamless and impermeable resin floor with coving between the floor and wall will minimize the
risk of accumulation in cracks and gaps of nanomaterials, by making at the same time easier to
clean and easily remove contaminants from the area.
• Manipulation under fume hood (compulsory).
• SAS entrance and exit (simple).
• Safety shower.
4.1.2. Industry
The recommended technical protective measures should be almost the same that are used in
the laboratory, although it must be ensured that the low-pressure room is >20 mPa and that the SAS
entrance and exit is double [90].
For SMEs (Small and Medium Size Enterprises), costs of some controls may become highly
expensive, if not prohibitive. Hence, these companies should consider alternatives out of their
organization as a strategy to follow controls within a restricted budget, such as [74]:
• Cooperation with academia and/or larger companies to have access to a high level of controls.
• Consider the acquisition of used laboratory equipment, but bear in mind to ensure they operate
under the correct specifications prior to use.
• Work with local economic and development groups to promote the importance of engineering
controls as enabler tools for nanotechnology commercialization for SMEs and promoting the
benefits of protecting workers, environment and community at large.
• Include discussion of EHS – Environmental Health and Safety rules in the business plan and
budget for high-level of controls possible needed.
Moreover, SMEs should consider the possibility to share, among themselves, high-level of
controls equipment.
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4.2. Personal Protection Equipment
Personal protection equipment (PPE) are devices or appliances designed to be used by an
individual worker for his protection against one or more health and safety hazards. When working
with nanomaterials the personal protective equipment should be preferably disposable, however,
when it is not possible it must be cleaned regularly or after use [84].
The principle of hierarchy of controls suggests that the first control measure should be to eliminate
the source of exposure. This will reduce implementing control measures that are more dependent on
workers’ attitudes. Involvement with PPE should be used only as a last resource. In the absence of
appropriate engineering controls PPE should be used, especially respiratory protection, as part of a
respiratory protection programme, including fit-testing [61].
4.2.1. Laboratory
Laboratories typically involve shorter work periods and exposure to smaller quantities of
nanomaterials. Hence, the PPE that should be adopted is [84,85,90,91]:
• Masks with P3 filters are advised for respiratory protection.
• To protect the eyes/face, use a face shield or lab goggles.
• Protection of the body parts with overalls with hood (Tyvek® style), since nonwoven clothing is
more efficient against penetration of NP than woven cotton.
• The use of two or more pairs of disposable gloves (nitrile, vinyl, latex, Neoprene®) should be
adopted and frequently replaced, especially for exposure to nanomaterials in liquid phase.
There are indispensable considerations and recommendations for the handling and disposal of
nanomaterials, including graphene and related derivatives.
Regarding their handling, research and working personnel should always wear appropriate
clothing and PPE, which include lab coats, gloves, well-fitted masks and appropriate eye
protection [8,89,92]. These materials should be in sealed containers, stored in closed cabinets and
samples’ size should be limited to small amounts and manipulated carefully, in order to avoid spills and
lower the risk of dermal exposure and the risk of airborne contamination [8,89]. Special considerations
during weighting or synthesis processes should also be undertaken. Free particles should not be
manipulated on the lab bench. Opening up sample recipients and weighing processes should be carried
out under a fume hood or at least in a glove box dedicated to that process [8,89,93]. Although the risk of
exposure is higher when handling powders than when working with dispersions [10], these should also
be contained, particularly if subjected to ultrasonication. Furthermore, these particles should not be
disposed of as general waste but should be bagged, labelled as nanoscale, and sent out for authorized
authorities as hazardous waste. If dispersed, the medium should first be neutralized if it is the case
and should be disposed of according to the hazardous chemical waste guidelines [8,89,93]. Adequate
cleaning procedures are also necessary. Work areas should be cleaned after use or at a minimum
at the end of each day. Any small powder spills should be removed by using wet wiping methods.
The contaminated surface should be cleaned until no trace of nanomaterial is visible. Larger spills
should be cleaned with a vacuum cleaner equipped with a HEPA filter. Research laboratories should
be routinely cleaned and checked regularly to ensure the maintenance of cleanliness. In addition,
all devices and equipment meant to prevent or eliminate work hazardous materials should undergo
maintenance and be checked regularly [8,92,93]. The regular realization of particle surveys is also
important to quantify any airborne particle contamination, since these can help with risk reduction
measurements if any contamination is detected, such as the rebalancing of the laboratory ventilation
systems [8].
4.2.2. Industry
The personal protective equipment that should be used in industry is similar to the laboratory.
However, in the industry, the work periods with nanomaterials are longer and they use higher quantities
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of nanomaterials in their products, the exposure is higher. Therefore, it is necessary to take into account
that the following should be additionally used [90,91,94,95]:
• A powered air respirator, because ensures better comfort for longer work periods (it is
recommended this system if the work lasts over 2 h). However, for shorter periods of exposure a
P3 filtering mask can be used.
• Similar to the laboratories, it should be used two or more pairs of disposable gloves
(nitrile, vinyl, latex, Neoprene®), but they should be replaced with higher frequency.
4.3. Training
Education and training are important tools for informing workers about hazards and protection
measures to ensure their safety and their performance.
In training, an aspect not always considered, is Prevention through Design (PtD), i.e., the concept
of Design with the objective to rule out occupational hazards to protect workers [74].
Hence, it is recommended to include the former concept in educational and training packages.
4.3.1. Laboratory
Before having to work with nanomaterials, all laboratory workers should undergo pertinent
training, in which they learn about health issues related to the use of these particles, standard procedures
for manipulating these materials and precautions to prevent exposure, hygiene requirements, and what
should be done in case of incident handlings [92]. All of these safe work instructions should also be
documented in a regularly updated and revised document, written in a clear and concise manner,
in order to allow all users (especially new ones) to be aware of all the risks associated with these
materials and all the procedures for safe handling and laboratory cleaning [8].
The training should be firstly basic training for the laboratory practice. Then, it must be
complemented with continuous training about nano manipulation, since regular discoveries are made
regarding the use and safety issues of these materials. Besides, the training should be complemented
with written working procedures [90].
4.3.2. Industry
It is suggested [61] as a best practice that workers potentially exposed to manufactured nanomaterials
(MNMs) should be educated on their risks and trained in how they can best manage the risks and protect
themselves. Besides following current guidelines, education and training should focus on those aspects of
manufactured nanomaterials that are additional to, or different from, education and training in the safe
handling of bulk material chemicals. Hence, the following topics should be included [61]:
• Hazards are specific to MNMs and different from the bulk material.
• Hazard classes are assigned to MNMs.
• Routes of exposure are important which workplace exposures have been measured and which
tasks put workers most at risk.
• How proposed OELs can be interpreted.
• When and how control banding, specific controls and PPE for MNMs can be used.
Normally, the workers face unknown risks regarding the exposure to nanomaterials, since the
legislation considered that the risks of nanomaterials are the same as the micro materials. So, a deeper
worker education and training initiatives are needed to prepare the nanotechnology workforce as the
field continues to develop. Similar training that is used for laboratories should be performed, although
with more frequency and the written working procedures should be regularly updated [90,96].
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4.4. Maintenance
Regular maintenance is essential to ensure safety and reliability of the workplace, since the lack of
maintenance can lead to dangerous situations, accidents and health problems.
4.4.1. Laboratory
In the laboratories maintenance activities, the workers should [90,97]:
• Perform the separation of the laboratory clothes from the outside ones (compulsory).
• Use safety containers for transportation of nanomaterials.
• Store in specific areas and separate cabins the nanomaterials. These cabinets must carry an
appropriate danger label.
• The workers that handle the nanomaterials in the laboratory should be the ones that cleans
the laboratory.
• The cleaning process should be wet to avoid the dispersion to the working atmosphere of
the nanoparticles.
• The residues should be treated as chemical/hazardous waste and deposited in double bagging
with a label that indicates the presence of nanomaterials in those wastes and include available
information characterizing known and suspected properties.
• In the case that nanoparticles are accidentally split, the workplace must be cleaned immediately
with a wet damp towel. Under no circumstances may residual materials be blown off the surface,
particularly in the case of nanomaterials.
• Use the same protective equipment’s during the cleaning and maintenance activities.
• Laboratory responsible must supervise the cleaning and maintenance activities.
4.4.2. Industry
In the industry, the same maintenance procedures that are used in the laboratories should be
adopted [90]. It should be considered that maintenance and cleaning operations may generate
aerosols and workplace contamination increasing the risk of exposures for workers. During preventive
maintenance, it is likely that safety devices (such as filtration elements) are “disconnected”, which means
the workers are immediately exposed if an error occurs. This implies a high risk of exposure that must
be managed with well trained workers [33].
4.5. Application of Safety Guidelines
To enforce the implementation of the safety guidelines, inspections should be conducted in parallel
with other control actions.
4.5.1. Laboratory
Besides regular inspections made by a health and safety specialist, to ensure the application of the
safety guidelines in the laboratories the following measures should be also applied [86]:
• Restricted access to the room (magnetic card access control system)
• Evidence about exposed people + board to record presence
• Medical surveillance to all persons that works with nanomaterials (once a year).
4.5.2. Industry
In industry, procedures similar to laboratories should be adopted, although besides the regular
inspections, annual audits should be also performed and the medical surveillance should be carried
out twice per year to all workers that handle nanomaterials [86].
Table 6 presents the proposed Occupational Exposure Limit Values for MNMs.
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Table 6. Proposed Occupational Exposure Limit Values for MNMs Adapted from [61].











Inhalation exposure: general MNM approach
MNM Fine particle matter
≤2500 nm
BOEL 30 ND ND
MNM Airborne particles from
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Fibres Fibrous NM BEL ND 0.01 ND
Fibres Carbon nanofibers CNFs OEL ND 0.01 ND
Fibres Carbon nanotubes CNTs,
insoluble NM with high
aspect ratio < 3:1
NRV ND 0.01 ND




INEL 1 ND ND
Carbon MWCNT 140 nm INEL 2 ND ND
Carbon Carbon nanotubes CNTs No effect concentration in air 2.5 ND ND
Carbon Carbon nanotube group,
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Carbon MWCNT DNEL acute inhalation,
pulmonary effect
201 ND ND
Carbon MWCNT DNEL dermal acute exposure 106 µg/kg
body weight
ND ND





BEL: benchmark exposure level; BOEL: benchmark occupational exposure level; BSI: British Standards Institute;
CNF: carbon nanofiber; CNT: carbon nanotube; DNEL: derived no-effect level; DWCNT: double-walled carbon
nanotube; INEL: indicative no-effect level; MNM: manufactured nanomaterial; MWCNT: multi-walled carbon
nanotube; ND: no data; NM: nanomaterial; NRV: nano reference value; OEL (PL): occupational exposure limit
period-limited; OEL: occupational exposure limit; PCVs: particle control values; REL: recommended exposure limit;
SWCNT: single-walled carbon nanotube.
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Other exposure limits can be identified. For instance, a REL of 1 µg/m3 EC for CNTs and carbon
nanofibers is proposed as an 8 h TWA respirable mass concentration [5,56]. BSI [63] suggested a BEL
of 0.01 fibres/cm3 and this has been established in UK, Germany and Switzerland [5,98].
4.6. Product Life Cycle
Research, development, and manufacturing of products with nanomaterials must take the
responsibility of environmental, safety and health impact of products at specific points during the
life cycle of the material from design up to disposal. In other words, they must assume product
stewardship. Safety data sheets must be provided and health and communication standards followed.
Besides product and hazards identification, composition, first-aid fire-fighting and accidental release
measures, handling and storage, properties (physical and chemical), stability and reactivity, Product
Stewardship may also include ecological, toxicological, disposal and transport information [80,99,100].
Moreover, it is equally important to include product safety testing, correct labelling, dangerous issues
during transportation, as well as a customer service.
5. Conclusions
Up to now, there is not enough knowledge on the possible adverse effects of CNTs and nano
graphene to ensure a complete workplace safety. Considering that CNTs and nano graphene are
increasingly used, and it is unlikely that in the near future, scientific and industrial entities stop using
nano-modified products, it is imperative to establish guidelines to handle these materials.
The identification of the potential hazards of CNTs and graphene to human health, during the
development of products with these materials, is imperative. Moreover, manufacturing “safe” end
products containing these nanomaterials will enhance the confidence of end-users, workers, researchers
and other relevant stakeholders.
In the present research work, some practical and simple safety and health management actions,
(such as technical, PPE, training, maintenance, application of safety guidelines and product life cycle
measures) for laboratories and industries that use nanomaterials in their workplaces, based on the
current state of knowledge, are proposed. These should be easily updated when more scientific
data will become available. Monitoring, adaptation, control, and review of measures in place have a
high importance.
Owing to an insufficient knowledge and application of the precautionary approach in practically
all methodologies for management of CNTs and nano graphene safety currently available, proactive
measures have an ‘over-protection’, that probably will be softened as knowledge will increase,
are generally better than having an insufficient protection; this environment has an important role in
educating people.
Thus, more research and collaborative efforts on nano safety are required in order to prevent,
minimize the potential hazards of nanomaterials and to fill the existing gaps.
Finally, to overcome health and safety concerns related with CNT and graphene products it
should be use Prevention, Precaution and Proactivity (in case of uncertainty go beyond what is
commonly required) measures. Above all, Design Integrating Safety, Sustainability and Salubrity
(DI3S) should be applied as soon as possible in the product development industries; to safeguard that
the manufacture CNTs and graphene products do not have negative impacts in the health and safety
of the workers, consumers and environment, making possible for the companies to achieve a truly safe
and sustainable management.
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